Key facts
- Status: Publicly Held.
- ·Watchlist + deal alerts for Locus Cell (ROCO: 06891)
- ·The full record, as it builds
Funding rounds
No funding rounds for Locus Cell (ROCO: 06891) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Locus Cell (ROCO: 06891)
Locus Cell Co Ltd focuses on contract development and manufacturing services for cell therapy-related products.
- Sector
- Healthcare
- HQ
- New Taipei, Taiwan
- Founded
- 2020
- Employees
- 33
- Website
- locus-cell.com/
- Ownership
- Publicly Held
Locus Cell (ROCO: 06891) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Locus Cell (ROCO: 06891) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Locus Cell (ROCO: 06891) in its N-PORT filings yet. We sweep new filings monthly.